Southern Star Research Logo

Meet us at ARCS Clinical Summit

November 19, 2025
Melbourne, Australia
ARCS Logo

Come and meet us

Our team will be available throughout this event to discuss how we can support your research initiatives. Whether you’re looking to start a new project, save an existing one or simply explore new partnership opportunities, we’re here to help.
Teresa

Teresa Ringeri

Director – Strategy Coordination

Meet us at the ARCS Clinical Summit 2025

November 19, 2025

Melbourne, Australia

Southern Star Research looks forward to participating in the Association of Regulatory and Clinical Scientists (ARCS) Clinical Summit 2025. This important event brings together professionals from across Australia’s clinical research sector to collaborate, exchange insights, and discuss key priorities that shape the future of clinical trials.

Founded by industry pioneers, Southern Star Research is built on intellectually engaged partnership, embedded quality, and principled action. This foundational philosophy continues to shape our culture today, guiding how we work, grow, and deliver exceptional outcomes for our clients, patients, and global health.

Our team’s depth of experience and scientific understanding means we anticipate challenges early, adapt quickly, and generate data that stands up to global scrutiny – a critical factor for successful regulatory submissions and investor confidence.

For over 15 years, our highly qualified clinical team has successfully supported trials across a wide range of therapeutic areas, spanning both common and complex indications. This extensive experience ensures your program will benefit from insights built across diverse patient populations and clinical challenges.

Why connect with Southern Star Research at the ARCS Clinical Summit 2025?

  • Benefit from local and global experience in clinical research and regulatory support
  • Take advantage of Australia’s fast approval pathways and generous R&D tax incentives
  • Access strong early-phase trial capabilities, including healthy volunteer studies
  • Expand into APAC with local insights and established regional partnerships

In addition to the above, we’re pleased to share that our SSR expert, Amanda Jubb, will be joining the Q&A panel at the upcoming ARCS Asia Pacific webinar, From Idea to Impact: Navigating the Challenges of Commercialising Novel Tech Beyond Australia, on 30 October 2025.

She’ll be contributing her insights alongside other industry experts following a presentation by Jason Sun on scaling medical technologies beyond Australia.

About the ARCS Clinical Summit 2025

The accredited ARCS event provides a valuable opportunity for sponsors, CROs, research sites, government agencies, and investors to gain a clear view of national reform progress and the emerging operational approaches that continue to strengthen Australia’s position in global clinical research. The 2025 program focuses on key themes influencing the sector’s direction.

At the Summit, you will:

  • Learn about Australia’s efficient research without compromising quality and streamlined regulatory processes.
  • Gain insights into navigating complex early-phase studies through infrastructure development and workforce readiness.
  • Access more inclusive research through meaningful collaboration with diverse communities.
  • Discover National One Stop Shop (NOSS) and insights from the Australian Commission on Safety and Quality in Health Care on the National Clinical Trials Governance Framework (NCTGF) journey.

Connect with our Director – Strategy Coordination at the ARCS Clinical Summit 2025

Fill out the form to schedule a meeting with Teresa Ringeri and learn how Southern Star Research can support your next clinical trial or research initiative.

Schedule a meeting

ARCS Clinical Summit GF

"*" indicates required fields

Southern Star Research values your privacy and is committed to protecting your personal information. We’ll only use your details for essential communications related to your account. From time to time, we’d like to share updates about our latest news, research, and other content that may interest you.

The Australian Advantage

Cost

Eligible organisations receive a 43.5% cash rebate on trial costs with the Australian Research & Development tax incentive.

Speed

Get you trial up and running in 8 weeks with streamlined ethics approvals and no need for an Investigational New Drug application.

Quality

World-class healthcare facilities and renowned experts ensure your data is accepted by international regulatory bodies like the FDA and EMA.

Sign up to our newsletter

Keep up to date with the latest news, updates and promotions

"*" indicates required fields

Southern Star Research values your privacy and is committed to protecting your personal information. We’ll only use your details for essential communications related to your account. From time to time, we’d like to share updates about our latest news, research, and other content that may interest you.

By clicking 'SUBSCRIBE NOW', you agree that Southern Star Research may collect and use your personal data for these marketing and communication purposes.

Copyright 2025 Southern Star Research Pty Ltd

Privacy Policy Legal Notice
icon of a head

Specialist experience

Each member of our Leadership Team boasts an average of 30 years experience. Our clients have access to an extraordinary group of Clinical Research professionals, whose experience covers Multinational Pharmaceutical companies, Biotechnology, Medical Device, CRO’s, research institutes, Universities, Industry Associations & Government Bodies. Together, we ensure that every aspect of your unique and novel drug study  clinical trial is handled with scientific precision, care, and foresight.

Our team has all of the tools, knowledge and experience to solve almost any issue that may arise during the complex clinical trial process.

We recognize that each study is unique and different and there are nuances that need to be resolved proactively.

Our advisory board of top-tier specialists in multiple therapeutic areas engage in the early stages from protocol design in constructive discussions to anticipate challenges and enhance study efficiency throughout the study.